You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for Patent: 10,973,934

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,973,934 protect, and when does it expire?

Patent 10,973,934 protects ELUCIREM and is included in one NDA.

This patent has nineteen patent family members in thirteen countries.

Summary for Patent: 10,973,934

Title:	Gadolinium bearing PCTA-based contrast agents
Abstract:	The present invention relates to the RRR/SSS pair of enantiomers of the of Gd(PCTA-tris-glutaric acid), the single enantiomers of the pair, the pharmaceutically acceptable salts thereof, their amide derivatives, and compositions comprising at least 50% of these compounds.
Inventor(s):	Napolitano Roberta, Lattuada Luciano, Baranyai Zsolt, Guidolin Nicole, Marazzi Giuseppe
Assignee:	BRACCO IMAGING S.P.A.
Application Number:	US16766619
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 10,973,934

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Guerbet	ELUCIREM	gadopiclenol	SOLUTION;INTRAVENOUS	216986-001	Sep 21, 2022		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial		Y			⤷ Try a Trial
Guerbet	ELUCIREM	gadopiclenol	SOLUTION;INTRAVENOUS	216986-002	Sep 21, 2022		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial		Y			⤷ Try a Trial
Guerbet	ELUCIREM	gadopiclenol	SOLUTION;INTRAVENOUS	216986-003	Sep 21, 2022		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial		Y			⤷ Try a Trial
Guerbet	ELUCIREM	gadopiclenol	SOLUTION;INTRAVENOUS	216986-004	Sep 21, 2022		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial		Y			⤷ Try a Trial
Guerbet	ELUCIREM	gadopiclenol	SOLUTION;INTRAVENOUS	216986-005	Sep 21, 2022		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial		Y			⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 10,973,934

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2019319599	⤷ Try a Trial
Brazil	112021001102	⤷ Try a Trial
Canada	3105610	⤷ Try a Trial
China	112533921	⤷ Try a Trial
Denmark	3687994	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.